Currently leading Curie.Bio, a virtual-first biotech company with operations across San Francisco, Boston, and New York, Lengauer brings a unique perspective to drug discovery that bridges scientific rigor with entrepreneurial vision.
Currently leading Curie.Bio, a virtual-first biotech company with operations across San Francisco, Boston, and New York, Lengauer brings a unique perspective to drug discovery that bridges scientific rigor with entrepreneurial vision.